An observational study in Anastomotic Leak Large Intestine and Anastomotic Leak Rectum, sponsored by National Research Oncology and Transplantology Center, Kazakhstan. Recruiting at 1 site in Kazakhstan. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-02-23.
Sponsored by National Research Oncology and Transplantology Center, Kazakhstan · Observational
The aim of this prospective observational study is to evaluate the effectiveness of the mobile application "Colorectal Leakage App" in the early diagnosis of anastomotic leakage after colorectal surgeries at the National Research Oncology Center in Astana, Kazakhstan.
Main Questions:
Participants in the study, individuals aged 18 and above undergoing colorectal surgeries, will be monitored by the mobile application "Colorectal Leakage App" in the postoperative period for early identification of anastomotic leakage.
Colorectal cancer ranks third among oncological diseases in Kazakhstan, both in men and women. Anastomotic leakage (AL) following colorectal surgeries is one of the most serious complications arising from colorectal surgical interventions. This condition is characterized by increased mortality and significant deterioration in the quality of life of patients. Additionally, the presence of AL after anterior resections for rectal cancer is associated with an increased risk of local disease recurrence. The frequency of AL varies between 2 and 19%, depending on risk factors, AL definition, and the level of anastomosis. Given the high likelihood and severe consequences of AL, a relevant task is its early detection and effective treatment.
Clinical signs of AL traditionally include fever, tachycardia, pain syndrome, purulent or fecal discharge through drainage, and dynamic bowel obstruction. These signs, combined with other clinical data, are integrated into a diagnostic-specific indicator known as the Dutch Leakage Score (DLS). This indicator is used as a standardized postoperative monitoring protocol for patients suspected of having AL, aiming to minimize delays in detecting this complication and, consequently, reduce early postoperative mortality.
In this prospective observational study, we aim to assess the effectiveness of the mobile application "Colorectal Leakage App" in the early detection of anastomotic leakage (AL) after colorectal surgeries. The study will be conducted at the National Research Oncology Center (NROC) in Astana, Kazakhstan, over one year. The primary goal is to evaluate the diagnostic effectiveness of the application in detecting AL after colorectal surgeries.
It is important to note that there is currently no up-to-date data on the number of colorectal cancer surgeries performed, and information on the frequency of AL after colorectal surgeries in the population of Kazakhstan is also lacking. Previous studies have shown that the effectiveness of the DLS algorithm is directly proportional to the frequency of AL. Therefore, it is assumed that the application of DLS may demonstrate different results in the conditions of Kazakhstan, which we also plan to measure through the "Colorectal Leakage App" mobile application.
Design of the study:
Prospective observational study, where the "Colorectal Leakage App" mobile application will be implemented in daily postoperative monitoring. Additionally, an assessment of the diagnostic effectiveness of this application will be conducted.
The "Colorectal Leakage App" is a mobile application that, based on an algorithm, provides an assessment of the risk of Anastomotic Leakage (AL) in patients after colorectal surgeries. The algorithm is built on the standardized postoperative monitoring protocol called "Dutch Leakage Score". After calculating the scores, the application provides recommendations for further actions.
Primary endpoints:
Secondary endpoints:
Postoperative monitoring with the "Colorectal Leakage App":
It is planned to implement standardized postoperative monitoring for patients who have undergone colorectal surgeries using the "Colorectal Leakage App." The application will include an algorithm based on the Dutch Leakage Score indicator. Each postoperative day, data entry at the patient's bedside will be carried out in the application.
The following information will also be collected: Preoperative risk factors for AL(age, gender, obesity, nutritional status, diabetes, cardiovascular diseases, renal insufficiency, inflammatory bowel diseases, ASAscore, bowel preparation); Surgery data (access, surgery type, anastomosis technique, duration of surgery, blood loss volume, formation of a preventive stoma, intraoperative and postoperative complications, pTNM).
Key points determining the conclusion of a patient's participation in the study will be: the detection of AL, patient discharge from the hospital, or patient death.
240 studies on the registry are indexed under Anastomotic Leak; 72 are open to participants now.
This study's planned enrollment of 120 is below the median of 166 across 111 observational studies indexed under Anastomotic Leak.
Browse Anastomotic Leak studies →National Research Oncology and Transplantology Center, Kazakhstan is the lead sponsor of 3 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Scheduled patients with benign and malignant colorectal diseases undergoing surgical treatment, including the creation of anastomoses (ileocolic, colocolic, colorectal anastomoses), with or without a preventive stoma.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A scale of how much an illness limits everyday activity. For people being assessed to join a study, scores run from 0 (fully active) to 4; lower is more active.
Studies most often ask for 0–1 or 0–2. Your doctor gives the score; the WHO scale uses the same steps. The full scale also has 5, which records death.
ECOG performance status
A scale of how much an illness limits everyday activity. For people being assessed to join a study, scores run from 0 (fully active) to 4; lower is more active.
Studies most often ask for 0–1 or 0–2. Your doctor gives the score; the WHO scale uses the same steps. The full scale also has 5, which records death.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
This group comprises patients who will be monitored using the "Colorectal Leakage App" based on the Dutch leakage score for early detection of anastomotic insufficiency after colorectal surgeries.
Diagnostic Test: "Colorectal Leakage App"
The "Colorectal Leakage App" is a mobile application designed to aid in the early detection of anastomotic insufficiency after colorectal surgeries. The app is based on the Dutch Leakage Score (DLS) algorithm, which is a standardized protocol for postoperative monitoring.
Diagnostic effectiveness of "Colorectal Leakage App".
Measurement of sensitivity, specificity, positive predictive value and negative predictive value of the mobile application "Colorectal Leakage App".
Time frame: 1 year
Frequency of anastomotic leakage after colorectal surgeries.
Measurement of frequency of anastomotic leakage after colorectal surgeries at the National Research Oncology Center (NROC) in Astana, Kazakhstan.
Time frame: 1 year
Mortality within 30 days
Mortality within 30 days
Time frame: 1 year
Delay in the diagnosis of anastomotic leakage
Number of days from the onset of the first signs of a leakage to the diagnosis of anastomotic leakage..
Time frame: 1 year
Duration of hospital stay.
Duration of hospital stay.
Time frame: 1 year
Number of days in the ICU.
Number of days in the ICU.
Time frame: 1 year
Number of days between surgery and detection of AL.
Number of days between surgery and detection of AL.
Time frame: 1 year
Plan to share: Undecided
Started Jan 2024 (actual). Primary completion is estimated for Jan 2025, 12 months after the start.
Of 50 non-industry observational studies under Anastomotic Leak, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 73. This study's planned 12 months is below that.
Counting every sponsor, half of 52 studies reached it within 33 months; a quarter within 23 and three quarters within 98.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Research Oncology and Transplantology Center, Kazakhstan